Disappointed with the failure to fund the UK’s “world-dominant” Covid tracker | Coronavirus

If anything was sweeping the world about Britain’s response to Covid-19, it was our surveillance system. From the World Health Organization to the Centers for Disease Control and Prevention (CDC), public health teams around the world praise the UK for infections. -Used our data to plan tracking capabilities and unique pandemic countermeasures.

Nevertheless, the Minister of Health has canceled future funding for React-1 research and other research projects. This decision was disappointing among leading scientists and researchers around the world questioning Britain’s ability to respond to future Covid threats.

Last week, researchers at Imperial College London unveiled the latest changes in the pandemic with the discovery that infections began to increase in people over the age of 55. Imperial scientists work with Ipsosmori to analyze the results of PCR tests for more than 100,000 people a month.

React-1 results, along with a weekly Covid infection survey by the Office for National Statistics (ONS), show accurate snapshots of the number of infected people and the most affected areas. Surveys are much more reliable than self-selection. Community test data that misses many asymptomatic cases.

Still, Professor Paul Elliott, director of Imperial’s React (real-time assessment of community infections) research, said last week that the future relies on funding from the Ministry of Health and funding will end this month.

In announcing the results of the 18th survey last week, “We have another round, so we’ll be on the scene from now until the end of March, but we don’t have any more money.”

Other studies, including the Zoe Covid app, which track people’s symptoms and cost £ 5 million over the last two years, are also unfunded. Professor Tim Spector, who leads the study, said he received “a notice of just a few weeks.” “I strongly believe that the decision is a really bad mistake,” he said of the “disappointing news,” after being assured that funding would continue from the UK Health and Security Agency (UKHSA). He added that it only took. 1% of the funding required for ONS research.